Plant Advanced Technologies SA (EPA:ALPAT)
4.320
0.00 (0.00%)
Sep 11, 2026, 11:01 AM CET
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €4.86 million as of September 11, 2026. Its market cap has decreased by -52.75% in one year.
Market Cap
4.86M
Enterprise Value
8.77M
Revenue
1.65M
Ranking
n/a
PE Ratio
8.47
Stock Price
€4.32
ChartMarket Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has decreased from 6.22M to 4.86M, a decrease of -21.93%. That is a compound annual growth rate of -1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.86M | -47.21% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 23.05M |
| Aelis Farma | 13.79M |
| Advicenne | 12.85M |
| Aton | 11.76M |
| NFL Biosciences | 10.90M |
| TME Pharma | 10.11M |
| Poxel | 9.94M |
| Biophytis | 6.12M |